AI-powered cancer diagnosis company raises $55M

Ibex Medical Analytics, an artificial intelligence-powered cancer diagnostics, raised $55 million in series C financing.

Advertisement

Ibex’s Galen platform integrates AI into pathologists’ workflows. The platform has gone live at Pittsburgh-based UPMC, according to a Sept. 6 Ibex news release. The Israeli company will use the funding to expand further into the U.S.

Venture capital firm 83North led the funding round. The financing brought Ibex’s total capital raised to over $100 million.

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Digital Health

Advertisement

Comments are closed.